Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-02 9:54 pm Purchase | 2026-01-29 | 13D | Lexicon Pharmaceuticals, Inc. LXRX | Invus Global Management LLC | 154,734,327 36.200% | 154,734,327 (New Position) | Filing History |
| 2026-01-27 2:18 pm Purchase | 2026-01-21 | 13G | enGene Holdings Inc. ENGN | Invus Global Management LLC | 4,244,559 6.300% | 4,244,559 (New Position) | Filing History |
| 2025-11-12 10:29 am Purchase | 2025-09-30 | 13G | vTv Therapeutics Inc. VTVT | Invus Global Management LLC | 393,098 9.400% | 45,015 (+12.93%) | Filing History |
| 2025-10-23 5:05 pm Purchase | 2025-10-16 | 13G | Rani Therapeutics Holdings, Inc. RANI | Invus Global Management LLC | 9,825,911 9.990% | 9,825,911 (New Position) | Filing History |
| 2025-10-14 5:14 pm Purchase | 2025-10-06 | 13G | DBV Technologies S.A. DBVT | Invus Global Management LLC | 11,538,460 7.800% | 11,538,460 (New Position) | Filing History |
| 2025-10-02 5:04 pm Purchase | 2025-09-26 | 13G | Tenax Therapeutics, Inc. TENX | Invus Global Management LLC | 427,141 9.400% | 427,141 (New Position) | Filing History |
| 2025-09-22 5:22 pm Purchase | 2025-09-19 | 13G | Tango Therapeutics, Inc. TNGX | Invus Global Management LLC | 5,883,188 5.300% | 5,883,188 (New Position) | Filing History |
| 2025-09-22 3:15 pm Purchase | 2025-09-18 | 13G | Rezolute, Inc. RZLT | Invus Global Management LLC | 4,870,000 5.400% | 4,870,000 (New Position) | Filing History |
| 2025-09-08 5:43 pm Purchase | 2025-08-29 | 13G | vTv Therapeutics Inc. VTVT | Invus Global Management LLC | 348,083 9.990% | 348,083 (New Position) | Filing History |
| 2025-07-31 2:56 pm Purchase | 2025-06-30 | 13G | Bicara Therapeutics Inc. Common Stock BCAX | Invus Global Management LLC | 5,216,969 9.600% | 2,144,142 (+69.78%) | Filing History |
| 2025-07-31 2:48 pm Purchase | 2025-06-30 | 13G | Inventiva S.A. IVA | Invus Global Management LLC | 14,814,813 10.600% | 7,407,407 (+100.00%) | Filing History |
| 2025-07-29 1:21 pm Purchase | 2025-06-30 | 13G | Kalaris Therapeutics Inc KLRS | Invus Global Management LLC | 282,586 1.500% | 282,586 (New Position) | Filing History |
| 2025-04-17 6:50 pm Purchase | 2025-03-31 | 13G | Solid Biosciences Inc. SLDB | Invus Global Management LLC | 7,415,905 9.600% | 3,666,864 (+97.81%) | Filing History |
| 2025-04-17 4:30 pm Purchase | 2023-12-31 | 13G | Nanobiotix S.A. NBTX | Invus Global Management LLC | 4,232,829 8.900% | 4,232,829 (New Position) | Filing History |
| 2025-04-11 4:43 pm Purchase | 2022-09-02 | 13G | Abivax S.A. ABVX | Invus Global Management LLC | 5,403,985 8.500% | 5,403,985 (New Position) | Filing History |
| 2025-03-31 5:04 pm Purchase | 2024-10-17 | 13G | Inventiva S.A. IVA | Invus Global Management LLC | 7,407,406 7.800% | 7,407,406 (New Position) | Filing History |
| 2025-02-12 4:30 pm Purchase | 2024-12-31 | 13G | Solid Biosciences Inc. SLDB | Invus Global Management LLC | 3,749,041 9.400% | 1,000,000 (+36.38%) | Filing History |
| 2025-02-12 4:30 pm Unchanged | 2024-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Invus Global Management LLC | 1,991,038 4.900% | 0 (Unchanged) | Filing History |
| 2025-02-12 4:30 pm Sale | 2024-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS | Invus Global Management LLC | 1,063,829 3.800% | -2,587,372 (-70.86%) | Filing History |
| 2025-02-12 4:30 pm Sale | 2024-12-31 | 13G | Gossamer Bio, Inc. GOSS | Invus Global Management LLC | 6,258,880 2.800% | -8,072,642 (-56.33%) | Filing History |